arginine has been researched along with Fanconi Anemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keck, JL; Manthei, KA; Voter, AF | 1 |
Bhanap, B; Niedzwiecki, A; Rath, M; Roomi, MW; Roomi, NW | 1 |
Amarachintha, S; Du, W; Erden, O; Pang, Q; Wilson, A | 1 |
Abou-Zahr, F; Kruyt, FA; Mok, H; Youssoufian, H | 1 |
Prindull, G; Stubbe, P | 1 |
5 other study(ies) available for arginine and Fanconi Anemia
Article | Year |
---|---|
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases | 2016 |
Repression of matrix metalloproteinases and inhibition of cell invasion by a nutrient mixture, containing ascorbic acid, lysine, proline, and green tea extract on human Fanconi anemia fibroblast cell lines.
Topics: Antioxidants; Apoptosis; Arginine; Ascorbic Acid; Cell Line; Cell Movement; Cell Proliferation; Fanconi Anemia; Humans; Lysine; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Proline; Tea | 2013 |
The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Topics: Animals; Antigens, Differentiation; Arginine; Carcinogenesis; Cell Cycle; DNA Damage; Fanconi Anemia; Fanconi Anemia Complementation Group Proteins; Hematopoietic Stem Cells; Humans; Luciferases; Methylation; Mice; Mice, Knockout; Mice, Transgenic; Protein-Arginine N-Methyltransferases; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amino Acids; Animals; Arginine; Binding Sites; Cell Line; Cell Nucleus; Cell Survival; COS Cells; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Fanconi Anemia Complementation Group G Protein; HeLa Cells; Humans; Microscopy, Fluorescence; Mitomycin; Molecular Sequence Data; Protein Binding; Proteins; Recombinant Fusion Proteins | 1999 |
Fanconi's anemia. II. Are multiple endocrine insufficiencies a substantial part of the disease?
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Anemia, Aplastic; Arginine; Blood Glucose; Body Height; Body Weight; Child; Child, Preschool; Endocrine Glands; Fanconi Anemia; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Secretion; Islets of Langerhans; Luteinizing Hormone; Male; Metyrapone; Pituitary Gland, Anterior; Testis; Testosterone; Thyroxine; Urea | 1975 |